“Long Term Efficacy, Safety, and Tolerability of Tildrakizumab in Epileptic Patient With Psoriasis and Eczema”. Dermatology Reports 14, no. 4 (November 21, 2022). Accessed June 19, 2025. https://journals.pagepress.org/dr/article/view/9447.